The National Institutes of Health (NIH) is set to expand its Alzheimer ’s disease Neuroimaging Initiative study. They are recruiting 550 new volunteers to help determine the changes that take place in the brains of older adults years before symptoms of Alzheimer ’s disease appear. They bill this study as the largest public-private partnership to date in Alzheimer’s disease research.
The NIH describes the recruitment as such:
Researchers are seeking new volunteers to join those already participating in the study as it enters a second phase, called ADNI2. Over the next five years, approximately 1,000 people aged 55 to 90 will be enrolled at approximately 55 sites in the United States and Canada. They will be followed to define any changes in brain structure and function as people transition from normal cognitive aging to mild cognitive impairment (MCI), often a precursor to Alzheimer’s, to Alzheimer’s dementia. The study will use imaging techniques and biomarker measures in blood and cerebrospinal fluid specially developed to track changes in the living brain. Researchers hope to identify who is at risk for Alzheimer’s, track progression of the disease and devise tests to measure the effectiveness of potential interventions.
This is an opportunity for people to give of themselves in hopes of improving the life of others in the future. To volunteer or learn more about ADNI, contact the NIA Alzheimer’s Disease Education and Referral (ADEAR) Center at 1-800-438-4380 or www.nia.nih.gov/Alzheimers.
Study sites recruiting volunteers in Canada are:
Montreal; Vancouver, B.C.; Toronto, London and Hamilton, Ontario.
The U.S. study sites recruiting volunteers are:
Ann Arbor, Mich.
Boston (two sites)
Chicago (two sites)
Irvine, Calif. (two sites)
Kansas City, Kan.
La Jolla, Calif.
Los Angeles (two sites)
New Haven, Conn.
New York (three sites)
Palo Alto, Calif.
Providence, R.I. (two sites)
Sun City, Ariz.
Washington (two sites)
West Palm Beach, Fla.